肝细胞癌中的编程细胞死亡:机制和治疗前景
Xiang'an Wu1, Jingying Cao2, Xueshuai Wan1
1Department of Liver Surgery, Peking Union Medical College Hospital, PUMC and Chinese Academy of Medical Sciences, Dongcheng, Beijing, 100730, China.
Cell death discovery
|August 8, 2024
概括
了解肝细胞癌 (HCC) 中的编程细胞死亡 (PCD) 是新疗法的关键. 本综述考察了HCC中的PCD途径,它们的相互作用,以及与耐药性的联系,并建议结合疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 对HCC的有效治疗策略需要对其潜在的细胞死亡机制有更深入的了解.
- 编程细胞死亡 (PCD) 途径显著影响HCC的发展和进展.
研究的目的:
- 审查与肝细胞癌 (HCC) 有关的各种编程细胞死亡 (PCD) 途径.
- 探索HC中不同PCD模式之间的潜在相互作用.
- 要突出破坏细胞死亡途径和HCC治疗中药物耐药性之间的联系.
主要方法:
- 编程细胞死亡 (PCD) 途径在肝细胞癌 (HCC) 的文献综述.
- 对HCC中亡,亡,烧亡,铁亡和免疫细胞死亡 (ICD) 的现有研究进行分析.
- 检查细胞死亡机制与治疗耐药性之间的关系.
主要成果:
- 多个PCD路径,包括亡,亡,烧亡,铁亡和ICD,都参与HCC.
- 有证据表明,由于共享的细胞因素,不同PCD途径之间存在潜在的相互作用.
- 在PCD路径中发生的干扰与HCC治疗中药物耐药性有关.
结论:
- 需要进一步的研究来澄清HCC中各种PCD途径的确切作用和相互作用.
- 向诱导细胞死亡与抗瘤治疗相结合,可能会提高HCC的治疗疗效.
- 解开细胞死亡模式的复杂相互作用可能会导致HCC的新型治疗突破.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
722
相关概念视频
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
